NovAccess Global Valuation
| XSNX Stock | USD 0.01 0.0006 6.25% |
NovAccess Global seems to be fairly valued based on Macroaxis valuation methodology. Our model forecasts the value of NovAccess Global from analyzing the firm fundamentals such as Shares Outstanding of 19.57 M, return on asset of -5.13, and Shares Owned By Institutions of 7.74 % as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that NovAccess Global's price fluctuation is out of control at this time. Calculation of the real value of NovAccess Global is based on 3 months time horizon. Increasing NovAccess Global's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since NovAccess Global is currently traded on the exchange, buyers and sellers on that exchange determine the market value of NovAccess Pink Sheet. However, NovAccess Global's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.009 | Real 0.00925 | Hype 0.01 | Naive 0.008698 |
The intrinsic value of NovAccess Global's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence NovAccess Global's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of NovAccess Global helps investors to forecast how NovAccess pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of NovAccess Global more accurately as focusing exclusively on NovAccess Global's fundamentals will not take into account other important factors: NovAccess Global Total Value Analysis
NovAccess Global is at this time estimated to have valuation of 5.75 M with market capitalization of 4.11 M, debt of 165.88 K, and cash on hands of 89.94 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the NovAccess Global fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.75 M | 4.11 M | 165.88 K | 89.94 K |
NovAccess Global Asset Utilization
One of the ways to look at asset utilization of NovAccess is to check how much profit was generated for every dollar of assets it reports. NovAccess Global secures a negative usage of assets of -5.13 %, losing $0.0513 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of NovAccess Global shows how discouraging it operates for each dollar spent on its assets.NovAccess Global Ownership Allocation
NovAccess Global maintains a total of 19.57 Million outstanding shares. NovAccess Global holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.NovAccess Global Profitability Analysis
Net Loss for the year was (1.72 M) with profit before overhead, payroll, taxes, and interest of 752.56 K.About NovAccess Global Valuation
Our relative valuation model uses a comparative analysis of NovAccess Global. We calculate exposure to NovAccess Global's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of NovAccess Global's related companies.NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio. Novaccess Global operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.
8 Steps to conduct NovAccess Global's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates NovAccess Global's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct NovAccess Global's valuation analysis, follow these 8 steps:- Gather financial information: Obtain NovAccess Global's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine NovAccess Global's revenue streams: Identify NovAccess Global's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research NovAccess Global's industry and market trends, including the size of the market, growth rate, and competition.
- Establish NovAccess Global's growth potential: Evaluate NovAccess Global's management, business model, and growth potential.
- Determine NovAccess Global's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate NovAccess Global's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
NovAccess Global Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 16.5 M | |
| Quarterly Earnings Growth Y O Y | -0.929 | |
| Retained Earnings | -62.2 M |
Additional Tools for NovAccess Pink Sheet Analysis
When running NovAccess Global's price analysis, check to measure NovAccess Global's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovAccess Global is operating at the current time. Most of NovAccess Global's value examination focuses on studying past and present price action to predict the probability of NovAccess Global's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovAccess Global's price. Additionally, you may evaluate how the addition of NovAccess Global to your portfolios can decrease your overall portfolio volatility.